Bourbon

Bourbon EBITDA per Share

The EBITDA per Share of Bourbon (2208.T) as of Nov 17, 2026 is 309.72 JPY. In the previous year, EBITDA per Share was 309.03 JPY — a change of 0.22% (higher).

EBITDA per Share

309.72JPY

YoY

0.22%

Last updated:

EBITDA per Share of Bourbon is 2026 309.72 JPY. EBITDA per Share of Bourbon was 2025 309.03 JPY. It decreases by 0.22% higher compared to the previous year.

The Bourbon EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
186.19 JPY
Jan 1, 2020
122.21 JPY
Jan 1, 2021
175.11 JPY
Jan 1, 2022
172.29 JPY
Jan 1, 2023
68.22 JPY
Jan 1, 2024
159.25 JPY
Jan 1, 2025
309.03 JPY
Jan 1, 2026
309.72 JPY
The Bourbon EBITDA per Share history
YEAREBITDA per ShareYoY
309.72JPY+0.22%
309.03JPY+94.05%
159.25JPY+133.43%
68.22JPY-60.40%
172.29JPY-1.61%
175.11JPY+43.29%
122.21JPY-34.36%
186.19JPY-13.88%
216.20JPY+7.38%
201.34JPY+10.51%
182.19JPY+29.97%
140.18JPY+75.16%
80.03JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bourbon Stock analysis

What does Bourbon do? Bourbon Corp sells cookies, wheat flour crackers, bean snacks, candy, deserts, rice biscuits, snacks, delicacies, chocolates, chewing gums, mineral water, coffee, cocoa beverages, other soft drinks, powdered cocoa, liquor, rice, bread, and instant ramen in China, Japan, and overseas. The company also provides insurance agency services, market research, and the sale of Xyltech, a growth control basic culture solution for regenerative medicine research. Products are sold to consumers and businesses in the food and beverage sector, while Xyltech targets research institutions and medical facilities. The firm's primary revenue streams come from the direct sale of its food and beverage products and the distribution of Xyltech to specialized markets. Bourbon Corp's main product lines include cookies, snacks, and beverages, which are distributed across multiple regions. The company's insurance agency business serves as an additional service for clients seeking risk management solutions. Market research services cater to corporate clients needing consumer insights. Xyltech is sold to research institutions and medical facilities focused on regenerative medicine, generating revenue from specialized scientific applications. The firm's portfolio spans consumer-facing food products like rice biscuits and instant ramen, alongside B2B services such as market research and insurance agency. Xyltech represents a niche offering within the biotechnology sector, appealing to medical research entities. Revenue is derived from both direct consumer sales of food and beverage items and the targeted distribution of Xyltech to research-focused clients. Bourbon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bourbon stock

EBITDA per Share of Bourbon is 309.72 JPY in 2026.

EBITDA per Share of Bourbon changed from 309.03 JPY to 309.72 JPY, representing a 0.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Bourbon since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Bourbon

All Key Metrics — Bourbon